MOVE
Price
$5.65
Change
+$0.33 (+6.20%)
Updated
Dec 20 closing price
86 days until earnings call
NVCR
Price
$30.83
Change
+$0.43 (+1.41%)
Updated
Dec 20, 04:59 PM (EDT)
59 days until earnings call
Ad is loading...

MOVE vs NVCR

Header iconMOVE vs NVCR Comparison
Open Charts MOVE vs NVCRBanner chart's image
Movano
Price$5.65
Change+$0.33 (+6.20%)
Volume$108.42K
CapitalizationN/A
NovoCure
Price$30.83
Change+$0.43 (+1.41%)
Volume$22.02K
CapitalizationN/A
MOVE vs NVCR Comparison Chart
Loading...
MOVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MOVE vs. NVCR commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MOVE is a Hold and NVCR is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (MOVE: $5.65 vs. NVCR: $30.80)
Brand notoriety: MOVE and NVCR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MOVE: 164% vs. NVCR: 121%
Market capitalization -- MOVE: $24.5M vs. NVCR: $1.66B
MOVE [@Medical Specialties] is valued at $24.5M. NVCR’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MOVE’s FA Score shows that 0 FA rating(s) are green whileNVCR’s FA Score has 1 green FA rating(s).

  • MOVE’s FA Score: 0 green, 5 red.
  • NVCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both MOVE and NVCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MOVE’s TA Score shows that 5 TA indicator(s) are bullish while NVCR’s TA Score has 5 bullish TA indicator(s).

  • MOVE’s TA Score: 5 bullish, 5 bearish.
  • NVCR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both MOVE and NVCR are a good buy in the short-term.

Price Growth

MOVE (@Medical Specialties) experienced а -12.54% price change this week, while NVCR (@Medical Specialties) price change was -7.81% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

MOVE is expected to report earnings on Mar 19, 2025.

NVCR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCR($1.66B) has a higher market cap than MOVE($24.5M). NVCR YTD gains are higher at: 106.296 vs. MOVE (-51.796). MOVE has higher annual earnings (EBITDA): -31.4M vs. NVCR (-177.45M). NVCR has more cash in the bank: 911M vs. MOVE (7.67M). MOVE has less debt than NVCR: MOVE (204K) vs NVCR (596M). NVCR has higher revenues than MOVE: NVCR (509M) vs MOVE (0).
MOVENVCRMOVE / NVCR
Capitalization24.5M1.66B1%
EBITDA-31.4M-177.45M18%
Gain YTD-51.796106.296-49%
P/E RatioN/AN/A-
Revenue0509M-
Total Cash7.67M911M1%
Total Debt204K596M0%
FUNDAMENTALS RATINGS
NVCR: Fundamental Ratings
NVCR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MOVENVCR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 12 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Ad is loading...
MOVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCSF17.230.28
+1.65%
Bain Capital Specialty Finance
CC17.720.25
+1.43%
Chemours Company (The)
GIB109.440.42
+0.39%
CGI
NEWP1.25-0.02
-1.96%
New Pacific Metals Corp
DARE2.71-0.27
-9.06%
Dare Bioscience Inc.

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with FLGT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then FLGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
+1.32%
FLGT - NVCR
40%
Loosely correlated
-2.19%
VCYT - NVCR
39%
Loosely correlated
+4.66%
MASS - NVCR
38%
Loosely correlated
+6.19%
KIDS - NVCR
38%
Loosely correlated
-0.93%
GH - NVCR
37%
Loosely correlated
+1.73%
More